StatCounter

venerdì 24 maggio 2019

ESMO European Society for Medical Oncology

FDA Approves Dalteparin Sodium for Venous Thromboembolism in Paediatric Patients

Approval is based on evidence from two clinical trials in paediatric patients with or without cancer